Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study.
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Pregabalin (Primary)
- Indications Abdominal pain; Cancer pain
- Focus Therapeutic Use
- Acronyms PANPAIN1
- 30 Sep 2016 Results of preliminary analysis assessing efficacy, presented at the 16th World Congress on Pain
- 30 Mar 2016 Planned primary completion date changed from 1 Aug 2015 to 1 Jun 2017 as per ClinicalTrials.gov record.
- 30 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017 as per ClinicalTrials.gov record.